| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
4,652 |
3,411 |
$354K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,534 |
2,716 |
$88K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,297 |
1,007 |
$79K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,390 |
1,906 |
$60K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
858 |
820 |
$47K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
547 |
434 |
$36K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
814 |
761 |
$33K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
238 |
38 |
$31K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
849 |
623 |
$31K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
976 |
923 |
$29K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
515 |
418 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
554 |
428 |
$19K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
166 |
124 |
$13K |
| 99385 |
|
167 |
118 |
$13K |
| 99233 |
Prolong inpt eval add15 m |
390 |
96 |
$9K |
| 99386 |
|
62 |
55 |
$5K |
| 99383 |
|
59 |
49 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
68 |
56 |
$3K |
| 99223 |
Prolong inpt eval add15 m |
43 |
39 |
$3K |
| 99384 |
|
33 |
32 |
$2K |
| A4927 |
Gloves, non-sterile, per 100 |
381 |
303 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
15 |
12 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
34 |
34 |
$751.20 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12 |
12 |
$266.20 |
| 99072 |
|
39 |
22 |
$75.00 |
| A4245 |
Alcohol wipes, per box |
161 |
115 |
$0.00 |
| A4928 |
Surgical mask, per 20 |
163 |
116 |
$0.00 |
| S5175 |
Laundry service, external, professional; per order |
163 |
116 |
$0.00 |
| E0700 |
Safety equipment, device or accessory, any type |
163 |
116 |
$0.00 |
| A9270 |
Non-covered item or service |
160 |
115 |
$0.00 |